Updated Jul 16, 2026
Kalif Eliyahu Sharon has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $20.73M.

Eliyahu Sharon Kalif is identified in the SEC filing context as an executive at Teva Pharmaceutical Industries Ltd, serving as Executive Vice President and Chief Financial Officer as of January 29, 2026 (SEC CIK 0001798443). The filing indicates no reported purchases or sales, suggesting routine fiduciary activity. Based on the SEC context, Kalif is positioned as a senior financial leader overseeing Teva’s global finance functions within a leading global generic drug company.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | S — Open-market sale | 106.6K | $34.10 | $3.63M |
| 2026-05-18 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | S — Open-market sale | 153.3K | $35.61 | $5.46M |
| 2026-03-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | M — Option exercise | 19.9K | — | |
| 2026-03-06 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | M — Option exercise | 23.3K | — | |
| 2026-03-06 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | M — Option exercise | 33.5K | — | |
| 2026-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | M — Option exercise | 141.5K | — | |
| 2026-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | M — Option exercise | 49.8K | — | |
| 2026-03-02 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | S — Open-market sale [10b5-1] | 345.8K | $33.64 | $11.63M |
Eliyahu Sharon Kalif is identified in the SEC filing context as an executive at Teva Pharmaceutical Industries Ltd, serving as Executive Vice President and Chief Financial Officer as of January 29, 2026 (SEC CIK 0001798443). The filing indicates no reported purchases or sales, suggesting routine fiduciary activity. Based on the SEC context, Kalif is positioned as a senior finan…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($20.73M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kalif Eliyahu Sharon profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.